Itraconazole therapy for onychomycosis: Case reports

Cutis

Volumn 58, Issue 5, 1996, Pages 371-374

  Kirshbaum, Bernard A ^a   Cynwyd, Bala ^a  

^a Allegheny University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CICLOPIROXOLAMINE; GRISEOFULVIN; ITRACONAZOLE;

ADULT; AGED; ARTICLE; CASE REPORT; DERMATOPHYTE; DRUG CAPSULE; DRUG EFFICACY; FINGER NAIL; HUMAN; MALE; NAIL COLOR; ONYCHOMYCOSIS; ORAL DRUG ADMINISTRATION; PRESCRIPTION; TOPICAL DRUG ADMINISTRATION;

AGED; ANTIFUNGAL AGENTS; HUMANS; ITRACONAZOLE; MALE; MIDDLE AGED; ONYCHOMYCOSIS; TREATMENT OUTCOME;

EID: 0029844893     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Zuehlke RI, Caplan RM, Sulzberger MB: Fungal Infections by Dermatophytes. San Francisco, Institute of Dermatologic Communication and Education, 1977.
2. Rippon JAR: Medical Mycology, 3rd edition. Philadelphia, WB Saunders, 1988, 210.
3. Achten G, Wanet-Rouard J: Onychomycosis in the laboratory. Mykosen Suppl 1: 125-127, 1978.
4. McAleer R: Fungal infections of the nails in Western Australia. Mycopathologia 73: 115-120, 1981.
5. Willemsen M: Changing patterns in superficial infections: focus on onychomycosis. J. Eur Acad Dermatol Venereol 2(Suppl 1): S6-S11, 1993.
6. Piérard GE, Arrese-Estrada J, Piérard-Franchimont C: Treatment of onychomycosis: traditional approaches. J Am Acad Dermatol 29: 1, S41-S45, 1993.
7. Matthieu L, De Doncker P, Cauwenbergh G, et al: Itraconazole penetrates the nail via the nail matrix and the nail bed: an investigation in onychomycosis. Clin Exp Dermatol 16: 374-376, 1991.
8. Warnock DW: New pharmacological concepts in antimycotic treatment. J Eur Acad Dermatol Venereol 2(Suppl 1): S19-S25, 1993.
9. Roseeuw D, De Doncker P: New approaches to the treatment of onychomycosis. J Am Acad Dermatol 29: 1, S45-S50, 1993.
10. Willemesen M, De Doncker P, Willems SJ, et al: Posttreatment itraconazole levels in the nail. J Am Acad Dermatol 26: 731-735, 1992.
11. Hay RJ: Risk/benefit ratio of modern antifungal therapy: focus on hepatic reactions. J Am Acad Dermatol 29: 1, S50-S54, 1993.